Advanced search
Publication Cover
Leukemia & Lymphoma Volume 61, 2020 - Issue 5
Submit an article Journal homepage
117
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

High plasma D-dimer level is a poor prognostic factor for patients with waldenström macroglobulinemia

Xin CaoDepartment of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China; ;Key Laboratory of Hematology of Nanjing Medical University, Nanjing, China; ;Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China; ;Department of Hematology, Affiliated Hospital of Nantong University, Nantong, ChinaView further author information
,
Yi-Lin KongDepartment of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China; ;Key Laboratory of Hematology of Nanjing Medical University, Nanjing, China; ;Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China; View further author information
,
Li WangDepartment of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China; ;Key Laboratory of Hematology of Nanjing Medical University, Nanjing, China; ;Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China; View further author information
,
Hua-Yuan ZhuDepartment of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China; ;Key Laboratory of Hematology of Nanjing Medical University, Nanjing, China; ;Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China; View further author information
,
Jin-Hua LiangDepartment of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China; ;Key Laboratory of Hematology of Nanjing Medical University, Nanjing, China; ;Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China; View further author information
,
Yi XiaDepartment of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China; ;Key Laboratory of Hematology of Nanjing Medical University, Nanjing, China; ;Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China; View further author information
,
Lei FanDepartment of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China; ;Key Laboratory of Hematology of Nanjing Medical University, Nanjing, China; ;Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China; View further author information
,
Wen-Yu ShiDepartment of Hematology, Affiliated Hospital of Nantong University, Nantong, ChinaView further author information
,
Hong LiuDepartment of Hematology, Affiliated Hospital of Nantong University, Nantong, ChinaView further author information
,
Jian-yong LiDepartment of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China; ;Key Laboratory of Hematology of Nanjing Medical University, Nanjing, China; ;Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China; View further author information
&
Wei XuDepartment of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China; ;Key Laboratory of Hematology of Nanjing Medical University, Nanjing, China; ;Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China; Correspondence[email protected]
View further author information
 show all
Pages 1140-1146 | Received 12 Aug 2019, Accepted 21 Dec 2019, Published online: 13 Jan 2020

References

  • Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375–2390.
  • Leblond V, Kastritis E, Advani R, et al. Treatment recommendations from the Eighth International Workshop on Waldenström's Macroglobulinemia. Blood. 2016;128(10):1321–1328.
  • Gertz MA, Abonour R, Heffner LT, et al. Clinical value of minor responses after 4 doses of rituximab in Waldenström macroglobulinaemia: a follow-up of the Eastern Cooperative Oncology Group E3A98 trial. Br J Haematol. 2009;147(5):677–680.
  • Blackwell K, Haroon Z, Broadwater G, et al. Plasma D-dimer levels in operable breast cancer patients correlate with clinical stage and axillary lymph node status. J Clin Oncol. 2000;18(3):600–608.
  • İnal T, Anar C, Polat G, et al. The prognostic value of D-dimer in lung cancer. Clin Respir J. 2015;9(3):305–313.
  • Man YN, Wang YN, Hao J, et al. Pretreatment plasma D-dimer, fibrinogen, and platelet levels significantly impact prognosis in patients with epithelial ovarian cancer independently of venous thromboembolism. Int J Gynecol Cancer. 2015;25(1):24–32.
  • Liu B, Li B, Zhou P, et al. Prognostic value of pretreatment plasma D-dimer levels in patients with diffuse large B cell lymphoma (DLBCL). Clin Chim Acta. 2018;482:191–198.
  • Bi XW, Wang L, Zhang WW, et al. High pretreatment D-Dimer levels correlate with adverse clinical features and predict poor survival in patients with natural killer/T-Cell lymphoma. PLoS One. 2016;11(3):e0152842.
  • Rubio-Jurado B, Tello-González A, Bustamante-Chávez L, et al. Circulating levels of urokinase-type plasminogen activator receptor and D-dimer in patients with hematological malignancies. Clin Lymphoma Myeloma Leuk. 2015;15(10):621–626.
  • Owen RG, Kyle RA, Stone MJ, et al. VIth International Workshop on Waldenström macroglobulinaemia. Response assessment in Waldenström macroglobulinaemia: update from the VIth International Workshop. Br J Haematol. 2013;160(2):171–176.
  • Arpaia G, Carpenedo M, Verga M, et al. D-dimer before chemotherapy might predict venous thromboembolism. Blood Coagul Fibrinolysis. 2009;20(3):170–175.
  • Weitz JI, Fredenburgh JC, Eikelboom JW. A test in context: D-Dimer. J Am Coll Cardiol. 2017;70(19):2411–2420.
  • Zhu LR, Li J, Chen P, et al. Clinical significance of plasma fibrinogen and D-dimer in predicting the chemotherapy efficacy and prognosis for small cell lung cancer patients. Clin Transl Oncol. 2016;18(2):178–188.
  • Tas F, Ciftci R, Kilic L, et al. Clinical and prognostic significance of coagulation assays in gastric cancer. J Gastrointest Canc. 2013;44(3):285–292.
  • Kodama J, Seki N, Fukushima C, et al. Elevated preoperative plasma D-dimer levels and the incidence of venous thromboembolism in Japanese females with gynecological cancer. Oncol Lett. 2013;5(1):299–304.
  • Anagnostopoulos A, Zervas K, Kyrtsonis M, et al. Prognostic value of serum beta2-microglobulin in patients with Waldenstrom's macroglobulinemia requiring treatment. Clin Lymphoma Myeloma. 2006;7(3):205–209.
  • Kastritis E, Kyrtsonis MC, Hadjiharissi E, et al. Validation of the International Prognostic Scoring System (IPSS) for Waldenstrom's macroglobulinemia (WM) and the importance of serum lactate dehydrogenase (LDH). Leuk Res. 2010;34(10):1340–1343.
  • Bang SM, Seo JW, Park KU, et al. Molecular cytogenetic analysis of Korean patients with Waldenström macroglobulinemia. Cancer Genet Cytogenet. 2010;197(2):117–121.
  • Short NJ, Connors JM. New oral anticoagulants and the cancer patient. Oncologist. 2014;19(1):82–93.
  • Buller HR, van Doormaal FF, van Sluis GL, et al. Cancer and thrombosis: from molecular mechanisms to clinical presentations. J Thromb Haemost. 2007;5 (Suppl 1):246–254.
  • Kasthuri RS, Taubman MB, Mackman N. Role of tissue factor in cancer. J Clin Oncol. 2009;27(29):4834–4838.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.